A comparison of the immunogenicity and descriptive safety of a live attenuated herpes zoster vaccine and the GSK herpes zoster recombinant HZ/su candidate vaccine in 50-59 year old and 70-85 year old vaccine recipients.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Adult Infectious Disease Clinical Trials Center
Study ID
Protocol Number: 13-3192
More information available at ClinicalTrials.gov: NCT02114333
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers